nach oben

Erschienen in:

01.06.2013 | Original Paper

Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months

verfasst von: Bruno Scheller, Dieter Fischer, Yvonne P. Clever, Franz X. Kleber, Ulrich Speck, Michael Böhm, Bodo Cremers

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

We report a male with a coronary bifurcation lesion in the mid circumflex artery (CX). After predilatation, the lesion was treated with two drug-coated balloons (DCB). Primary success in the posterolateral branch was good; however the CX lesion had a residual stenosis including a non-flow-limiting type A dissection. After 6 months, angiography showed slight lumen enlargement in both branches of the bifurcation. Intravascular ultrasound identified about 35 % atherosclerotic plaque load within the inner area of the bifurcation but more than 50 % concentric atherosclerotic plaque burden in the vessel areas proximal and distal to the DCB-treated area.

Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. New Engl J Med 316:701–706PubMedCrossRef

Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New Engl J Med 346:1773–1780PubMedCrossRef

Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRef

Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R (2009) One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2:625–628PubMedCrossRef

Scheller B, Hehrlein C, Bocksch W et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New Engl J Med 355:2113–2124PubMedCrossRef

Tepe G, Zeller T, Albrecht T et al (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New Engl J Med 358:689–699PubMedCrossRef

Scheller B, Clever YP, Kelsch B et al (2012) Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv 5:323–330PubMedCrossRef

Unverdorben M, Vallbracht C, Cremers B et al (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119:2986–2994PubMedCrossRef

Unverdorben M, Kleber FX, Heuer H et al (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99:165–174PubMedCrossRef

10.

Wohrle J, Birkemeyer R, Markovic S et al (2011) Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 97:1338–1342PubMedCrossRef

11.

Rosli R, Zambahari R et al (2011) Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroInterv J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol 7:K83–K91

12.

Habara S, Mitsudo K, Kadota K et al (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4:149–154PubMedCrossRef

13.

Rittger H, Brachmann J, Sinha AM, et al (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59(15):1377–1382

14.

Wohrle J, Zadura M, Mobius-Winkler S et al (2012) SeQuent Please World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 60:1733–1738PubMedCrossRef

15.

Kleber FX, Mathey DG, Rittger H, Scheller B (2011) How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention 7(Suppl K):K125–K128PubMedCrossRef

16.

Werk M, Albrecht T, Meyer DR et al (2012) Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 5:831–840PubMedCrossRef

17.

Gruntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263PubMedCrossRef

18.

Serruys PW, Onuma Y, Dudek D et al (2011) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58:1578–1588PubMedCrossRef

19.

Diletti R, Farooq V, Girasis C et al (2013) Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart 99:98–105PubMedCrossRef

Titel: Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months
verfasst von: Bruno Scheller
Dieter Fischer
Yvonne P. Clever
Franz X. Kleber
Ulrich Speck
Michael Böhm
Bodo Cremers
Publikationsdatum: 01.06.2013
Verlag: Springer-Verlag
Erschienen in: Clinical Research in Cardiology / Ausgabe 6/2013
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-013-0556-3

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months

Abstract

Neu im Fachgebiet Kardiologie

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model

Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban

Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry

Ventricular pressure–volume loops obtained by 3D real-time echocardiography and mini pressure wire—a feasibility study

Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany

Neu im Fachgebiet Kardiologie

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Update Kardiologie